Design and characterization of a polymeric MRI contrast agent based on PVA for in vivo living‐cell tracking
- 1 November 2010
- journal article
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 5 (6), 309-317
- https://doi.org/10.1002/cmmi.389
Abstract
A novel water‐soluble MRI contrast agent for in vivo living cell tracking was developed. Unlike the conventional in vivo cell tracking system based on superparamagnetic iron oxide beads, the newly developed contrast agent is eliminated from the body when the contrast agent exits the cells upon cell death, which makes living cell tracking possible. The contrast agent is composed of gadolinium chelates (Gd–DOTA) and a water‐soluble carrier, poly(vinyl alcohol) (PVA), which is known to interact with cells and tissues very weakly. Since the Gd–PVA was not taken up by cells spontaneously, the electroporation method was used for cell labeling. The delivered Gd–PVA was localized only in the cytosolic compartment of growing cells with low cytotoxicity and did not leak out of the living cells for long periods of time. This stability may be due to the weak cell‐membrane affinity of Gd–PVA, and did not affect cell proliferation at all. After cell labeling, signal enhancement of cells was observed in vitro and in vivo. These results indicate that Gd–PVA can visualize only the living cells in vivo for a long period of time, even in areas deep within large animal bodies. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 38 references indexed in Scilit:
- Role of Imaging in Cardiac Stem Cell TherapyJournal of the American College of Cardiology, 2007
- Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantationBlood, 2006
- Successful Stem Cell Therapy Using Umbilical Cord Blood-Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal ModelThe International Journal of Cell Cloning, 2006
- Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial InfarctionThe Annals of Thoracic Surgery, 2005
- In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular DiseaseCirculation, 2004
- Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart FailureCirculation, 2003
- Autologous bone-marrow stem-cell transplantation for myocardial regenerationThe Lancet, 2003
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularizationNature Medicine, 2002
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998